The number of people suffering from colon cancer in Croatia is still increasing – with 2169 cases this disease has become the fourth most common cause of death.
The European Commission’s Health and Public Health Report warned that colorectal cancer in Croatia was the second place in the EU’s ranking of deaths. The data is a reference to what they described, the disadvantages in providing health care and public health protection measures. One of the measures is the national program for early detection of the disease, however, according to HZJZ data, the average response rate is 21% and 19% tested !
According to EHIS data (European research in which Croatia participates), about 27 percent of people within three years have been tested for the hidden blood, and about 14 percent of the colonoscopy in ten years is still unsatisfactory and requires continuous education of the population. from HZJZ.
Everybody who is between 50 and 74 years old is invited to test the blood in the chair, at the address of their home, an envelope with the instructions, and they will be asked if they need colonoscopy . However, the national program clearly did not survive; The response, for example, in Slovenia is higher than 60 percent. The current cycle is underway, and the latest data show that in the US of the tested or discovered patients only 18 percent had cancer in the initial phase, while others already had metastases. This response to the preventive program prof. dr. sc. Stjepko Pleština will call the shamefully low, emphasizing the importance of educating citizens to respond – mortality grows because the disease is discovered late. Also, as head of the Clinic for Oncology of KBC Zagreb says, it is necessary to raise the level of treatment, preferably surgical, to define the oncological network and tell where, when and how the patients can and must heal!
The mode of treatment depends on the stage of the disease, the characteristics of the tumor, but also the patient itself. When planning a treatment plan, it is crucial to set the goal: whenever possible, the goal is cure, otherwise we try to prolong life and maintain its quality by controlling the symptoms of the disease, says prof. Pleština explaining that the prognosis differs depending on whether it is possible with a radical surgical procedure to completely remove the tumor and possibly its metastases if they exist.
icated, and when the disease is advanced and it is not possible to treat it surgically, chemotherapy with biological therapy is combined .
The use of multi-line systemic treatment significantly extends the life of patients with metastatic disease (about three years on average), but part of the patients who could not have been surgically treated and cured offered such a possibility, says Dr Pleština, adding that all the most effective therapy is available to us and that two more drugs will soon be available.
VESTIBULUM NEC PLACERAT ORCI. MAURIS VEHICULA
Vestibulum nec placerat orci. Mauris vehicula,Vestibulum nec placerat orci. Mauris vehicula